PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities
PMV Pharmaceuticals, a precision oncology company listed on Nasdaq under ticker PMVP, announced the pricing of an underwritten public offering raising approximately $50.8 million in gross proceeds by selling shares, pre-funded warrants, and accompanying warrants. The offering is expected to close shortly, with proceeds intended to support developme…